SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

Willett, B. J., Grove, J., MacLean, O. A., Wilkie, C., De Lorenzo, G., Furnon, W., Cantoni, D., Scott, S., Logan, N., Ashraf, S., Manali, M., Szemiel, A., Cowton, V., Vink, E., Harvey, W. T., Davis, C., Asamaphan, P., Smollett, K., Tong, L., Orton, R., & 22 othersHughes, J., Holland, P., Silva, V., Pascall, D. J., Puxty, K., da Silva Filipe, A., Yebra, G., Shaaban, S., Holden, M. T. G., Pinto, R. M., Gunson, R., Templeton, K., Murcia, P. R., PITCH Consortium, The COVID-19 Genomics UK (COG-UK) Consortium, Patel, A. H., Klenerman, P., Dunachie, S., Robertson, D. L., Palmarini, M., Ray, S. & Thomson, E. C., Aug 2022, In: Nature Microbiology. 7, 8, p. 1161-1179 19 p.

Research output: Contribution to journal › Article › peer-review